Anniek Strijdhorst is a Medical Doctor and PhD student at the Amsterdam University Medical Centers in the Netherlands at the department of Vascular Medicine and the department of Oncology. She started her PhD trajectory under the supervision of Prof. Dr. H.W.M. van Laarhoven, Dr. N. van Es and Dr. T.T.P. Seijkens in July 2022. Her research focuses on cardiovascular effects of immune therapy, with a special emphasis on investigating the etiology of (arterial) thromboembolic events in cancer patients undergoing immune checkpoint inhibitor treatment.
Immune checkpoint inhibition increases aortic inflammation on 18F-FDG PET/CT: a retrospective cohort study in patients with Merkel cell carcinoma receiving avelumab
Event: ESC Cardio-Oncology 2025
Topic: Cardio-Oncology
Session: Navigating cardiovascular challenges in immune checkpoint inhibitor and CAR-T therapy
